Overview Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 Status: Completed Trial end date: 2015-08-01 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the safety/tolerability and pharmacokinetics/pharmacodynamics of CKD-519. Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical